Dividend Power Score
A single, comprehensive score designed to measure the true strength of a company’s dividend.
This score combines three essential pillars of dividend quality:
Consistency – Measures how reliable the dividend has been over time, focusing on payment history, stability, and the absence of cuts or suspensions.
Payability – Assesses the company’s financial ability to sustain its dividend, taking into account cash flow, earnings coverage, balance sheet strength, and overall financial health.
Growth – Evaluates the long-term growth of both the dividend and the company’s share price, highlighting businesses that consistently increase payouts while creating shareholder value.
Higher scores identify companies that have historically delivered dependable income alongside sustained dividend growth and long-term capital appreciation.
Company Overview
Perrigo Company plc is a global consumer self-care and over-the-counter (OTC) pharmaceutical company focused on providing affordable health and wellness solutions. The company operates primarily in the consumer healthcare, OTC pharmaceuticals, and self-care medical products industries, with a strategic emphasis on store-brand and private-label offerings. Perrigo’s core revenue is driven by OTC medicines, vitamins and supplements, infant formula, personal care products, and prescription pharmaceuticals with limited competition.
The company serves major retailers, pharmacies, healthcare providers, and consumers across multiple regions, positioning itself as a leading supplier of private-label health products. Perrigo’s competitive advantage lies in its scale in store-brand manufacturing, regulatory expertise, and diversified product portfolio that spans everyday health categories. Founded in 1887 in the United States, Perrigo evolved from a niche pharmaceutical supplier into a global self-care company through decades of organic growth, strategic acquisitions, and a corporate re-domiciling to Ireland in 2013.
Business Operations
Perrigo operates through several primary business segments, most notably Consumer Self-Care Americas, Consumer Self-Care International, and Prescription Pharmaceuticals. These segments collectively generate revenue through the development, manufacturing, and distribution of branded and private-label OTC products, nutritional products, and select prescription medications. The company maintains vertically integrated capabilities, including product formulation, manufacturing, regulatory compliance, and supply chain management.
Operations span both domestic and international markets, with manufacturing facilities and distribution centers located across North America and Europe. Perrigo controls a broad portfolio of proprietary formulations, regulatory approvals, and manufacturing assets. Its structure includes numerous wholly owned subsidiaries supporting regional operations; however, the company does not rely heavily on joint ventures. Strategic retail partnerships with large mass merchants and pharmacy chains represent a critical component of its go-to-market model.
Strategic Position & Investments
Perrigo’s strategic direction centers on expanding its leadership in consumer self-care, simplifying its portfolio, and improving operating efficiency. In recent years, the company has prioritized investments in high-margin OTC categories, product innovation, and supply chain optimization, while divesting non-core or underperforming assets. This strategy reflects a shift toward fewer, stronger categories where Perrigo can maintain scale and pricing competitiveness.
The company has completed notable acquisitions and divestitures to sharpen its focus, including the integration of European consumer health assets and the exit from certain prescription pharmaceutical businesses. Perrigo continues to invest in emerging self-care trends such as digestive health, women’s health, and infant nutrition. While digital health and advanced therapeutics are monitored, Perrigo remains primarily focused on established, regulated consumer healthcare segments.
Geographic Footprint
Perrigo is headquartered in Ireland, with significant operational and commercial presence in North America and Europe. The United States represents the company’s largest market by revenue, supported by extensive manufacturing and distribution infrastructure. Internationally, Perrigo maintains strong positions in Western Europe, particularly in the United Kingdom, France, Germany, and Benelux countries.
Beyond Europe and North America, Perrigo has a more limited but growing presence in Australia and select other international markets through exports and regional subsidiaries. The company’s global footprint reflects its strategy of serving large, regulated consumer health markets with stable demand and established retail ecosystems.
Leadership & Governance
Perrigo is led by an executive team with experience across pharmaceuticals, consumer healthcare, and global operations. The leadership emphasizes disciplined capital allocation, portfolio focus, and operational execution, aligned with a long-term vision of expanding access to affordable self-care solutions.
Key executives include:
- Patrick Lockwood-Taylor – President and Chief Executive Officer
- Judy Brown – Executive Vice President and Chief Financial Officer
Publicly available sources consistently confirm the CEO and CFO roles listed above. Information regarding additional executive officers and board leadership shows variation across disclosures; therefore, data inconclusive based on available public sources for other specific executive roles.